Insider · CIK 0001374539

Allen Andrew R

Reports to the SEC for 7 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001374539

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-16	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+21.8K sh	—	—	21,781
2025-08-07	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+79.5K sh	—	—	79,456
2024-07-01	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director	AAward	+660K sh	—	—	660,000
2024-06-24	Gritstone bio, Inc.G Gift	Director, PRESIDENT AND CEO	GGift	−325K sh	—	—	1,124,275
2024-06-24	Gritstone bio, Inc.G Gift	Director, PRESIDENT AND CEO	GGift	−325K sh	—	—	985,360
2024-05-16	Gritstone bio, Inc.S Sale	Director, PRESIDENT AND CEO	SSale	−24.3K sh	$0.75	−$18.2K	985,360
2024-05-15	Gritstone bio, Inc.Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+615K sh	—	—	615,000
2024-05-15	Gritstone bio, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+47.9K sh	—	—	1,009,623
2024-02-01	Gritstone bio, Inc.Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+615K sh	—	—	615,000
2024-02-01	Gritstone bio, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+105K sh	—	—	899,345
2023-07-05	ADAPAdaptimmune Therapeutics PLC · Option to Purchase Ordinary SharesA Award	Director	AAward	+45.3K sh	—	—	45,348
2023-07-05	ADAPAdaptimmune Therapeutics PLC · Option to Purchase Ordinary SharesA Award	Director	AAward	+73.2K sh	—	—	73,212
2023-07-05	ADAPAdaptimmune Therapeutics PLC · Option to Purchase Ordinary SharesA Award	Director	AAward	+56.9K sh	—	—	56,868
2023-07-05	ADAPAdaptimmune Therapeutics PLC · Option to Purchase Ordinary SharesA Award	Director	AAward	+152K sh	—	—	152,376
2023-07-05	ADAPAdaptimmune Therapeutics PLC · Option to Purchase Ordinary SharesA Award	Director	AAward	+110K sh	—	—	109,746
2023-07-05	ADAPAdaptimmune Therapeutics PLC · Option to Purchase Ordinary SharesA Award	Director	AAward	+110K sh	—	—	109,746
2023-07-03	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director	AAward	+500K sh	—	—	500,000
2023-06-01	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.8K sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.1K sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.1K sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,072 sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,270 sh	—	—	0
2023-02-02	Gritstone bio, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+739K sh	—	—	856,750
2022-12-15	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)A Award	Director	AAward	+16.8K sh	—	—	16,800
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−6,000 sh	—	—	0
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−12K sh	—	—	0
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−625 sh	—	—	0
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−1,250 sh	—	—	0
2022-07-01	Sierra Oncology, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−750 sh	—	—	0
2022-07-01	Sierra Oncology, Inc.D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−1,650 sh	$55.00	−$90.8K	0
2022-01-31	Gritstone bio, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+70K sh	—	—	118,200
2022-01-31	Gritstone bio, Inc.Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+410K sh	—	—	410,000
2021-12-09	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)A Award	Director	AAward	+12.1K sh	—	—	12,100
2021-06-11	Epizyme, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+40.6K sh	—	—	40,559
2021-06-11	Epizyme, Inc.A Award	Director	AAward	+8,060 sh	—	—	20,560
2021-06-08	Sierra Oncology, Inc.Stock Option (Right To Buy)A Award	Director, 10% Owner	AAward	+6,000 sh	—	—	6,000
2021-03-08	Gritstone bio, Inc.Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+290K sh	—	—	290,000
2021-01-07	Gritstone bio, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+48.2K sh	—	—	48,200
2020-12-10	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)A Award	Director	AAward	+12.1K sh	—	—	12,100
2020-06-09	Sierra Oncology, Inc.Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+12K sh	—	—	12,030
2020-05-29	Epizyme, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+14K sh	—	—	14,013
2020-03-16	Epizyme, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−12.5K sh	—	—	0
2020-03-16	Epizyme, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+12.5K sh	$9.33	+$117K	12,500
2020-02-25	Gritstone bio, Inc.Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+275K sh	—	—	275,000
2019-12-19	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)A Award	Director	AAward	−5,000 sh	—	—	5,000
2019-06-11	Sierra Oncology, Inc.Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+30K sh	—	—	30,000
2019-05-31	Epizyme, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+17.6K sh	—	—	17,633
2019-04-11	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)A Award	Director	AAward	+6,270 sh	—	—	6,270
2019-02-13	Gritstone bio, Inc.Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+180K sh	—	—	180,000

Recent filings

Accepted (ET)
Jun 184
Allen Andrew R0001193125-26-276056
SEC(opens sec.gov)
Aug 84
Allen Andrew R0000950170-25-106029
SEC(opens sec.gov)
Jul 14
Allen Andrew R0001104659-24-076887
SEC(opens sec.gov)
Jun 264
Allen Andrew R0001415889-24-018275
SEC(opens sec.gov)
May 174
Allen Andrew R0001415889-24-013657
SEC(opens sec.gov)
Feb 54
Allen Andrew R0001415889-24-002702
SEC(opens sec.gov)
Jul 54
Allen Andrew R0001104659-23-078197
SEC(opens sec.gov)
Jul 34
Allen Andrew R0001104659-23-077662
SEC(opens sec.gov)
Jun 14
Allen Andrew R0001104659-23-067082
SEC(opens sec.gov)

Companies

Address

C/O CULLINAN THERAPEUTICS, INC. ONE MAIN STREET, SUITE 1350

CAMBRIDGE, MA, 02142